U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07589608) titled 'A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight' on May 11.
Brief Summary: The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. Participation will last about 64 weeks.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: Macupatide
Administered SC
DRUG...